Regulatory role of CD39 and CD73 in tumor immunity

被引：6
|
作者：
Kaplinsky, Nicole [1 ]
Williams, Kada [1 ]
Watkins, Dean [1 ]
Adams, Molly [1 ]
Stanbery, Laura [2 ]
Nemunaitis, John [2 ]
机构：
[1] Univ Toledo, Coll Med, Toledo, OH 43614 USA
[2] Gradalis Inc, Dallas, TX 75006 USA
来源：
FUTURE ONCOLOGY | 2024年 / 20卷 / 19期
关键词：
adenosine pathway; antigen; CD39; CD73; ENTPD1; immunotherapy; tumor microenvironment; T-CELLS; EXTRACELLULAR ADENOSINE; ATP; DISEASE; GROWTH; CANCER; INHIBITION; THERAPY;
D O I：
10.2217/fon-2023-0871
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CD39 is the rate-limiting enzyme for the molecular signal cascade leading to the generation of ADP and adenosine monophosphate (AMP). In conjunction with CD73, CD39 converts adenosine triphosphate (ATP) to ADP and AMP, which leads to the accumulation of immunosuppressive adenosine in the tumor microenvironment. This review focuses on the role of CD39 and CD73 in immune response and malignant progression, including the expression of CD39 within the tumor microenvironment and its relationship to immune effector cells, and its role in antigen presentation. The role of CD39- and CD73-targeting therapeutics and cancer-directed clinical trials investigating CD39 modulation are also explored.
引用
收藏
页码：1367 / 1380
页数：14
相关论文
共 50 条
  • [21] The role of NK cells and CD39 in the immunological control of tumor metastases
    Zhang, Haiyan
    Vijayan, Dipti
    Li, Xian-Yang
    Robson, Simon C.
    Geetha, Nishamol
    Teng, Michele W. L.
    Smyth, Mark J.
    ONCOIMMUNOLOGY, 2019, 8 (06):
  • [22] Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade
    Yang, Rui
    Elsaadi, Samah
    Misund, Kristine
    Abdollahi, Pegah
    Vandsemb, Esten Nymoen
    Moen, Siv Helen
    Kusnierczyk, Anna
    Slupphaug, Geir
    Standal, Therese
    Waage, Anders
    Slordahl, Tobias S.
    Ro, Torstein Baade
    Rustad, Even
    Sundan, Anders
    Hay, Carl
    Cooper, Zachary
    Schuller, Alwin G.
    Woessner, Richard
    Borodovsky, Alexandra
    Menu, Eline
    Borset, Magne
    Sponaas, Anne Marit
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [23] CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment
    Neo, Shi Yong
    Yang, Ying
    Record, Julien
    Ma, Ran
    Chen, Xinsong
    Chen, Ziqing
    Tobin, Nicholas P.
    Blake, Emily
    Seitz, Christina
    Thomas, Ron
    Wagner, Arnika Kathleen
    Andersson, John
    de Boniface, Jana
    Bergh, Jonas
    Murray, Shannon
    Alici, Evren
    Childs, Richard
    Johansson, Martin
    Westerberg, Lisa S.
    Haglund, Felix
    Hartman, Johan
    Lundqvist, Andreas
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (03) : 1185 - 1198
  • [24] Host CD73 impairs anti-tumor immunity
    Salmi, Marko
    Jalkanen, Sirpa
    ONCOIMMUNOLOGY, 2012, 1 (02): : 247 - 248
  • [25] Regulation of intratumoral purine homeostasis and signaling via concerted action of alkaline phosphatases, CD39 and CD73
    Losenkova, K.
    Zeiner, J.
    Kukkonen-Macchi, A.
    Algars, A.
    Sundstrom, J.
    Jalkanen, S.
    Yegutkin, G. G.
    PURINERGIC SIGNALLING, 2018, 14 : S70 - S70
  • [26] Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways
    Giatromanolaki, Alexandra
    Kouroupi, Maria
    Pouliliou, Stamatia
    Mitrakas, Achilleas
    Hasan, Fatma
    Pappa, Aglaia
    Koukourakis, Michael, I
    LIFE SCIENCES, 2020, 259
  • [27] Protective role of hypoxia-inducible factor-1α-dependent CD39 and CD73 in fulminant acute liver failure
    Tak, Eunyoung
    Jung, Dong-Hwan
    Kim, Seok-Hwan
    Park, Gil-Chun
    Jun, Dae Young
    Lee, Jooyoung
    Jung, Bo-hyun
    Kirchner, Varvara A.
    Hwang, Shin
    Song, Gi-Won
    Lee, Sung-Gyu
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2017, 314 : 72 - 81
  • [28] Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73-Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes
    Ahmadi, Parimah
    Hartjen, Philip
    Kohsar, Matin
    Kummer, Silke
    Schmiedel, Stefan
    Bockmann, Jan-Hendrik
    Fathi, Anahita
    Huber, Samuel
    Haag, Friedrich
    Schulze zur Wiesch, Julian
    CELLS, 2020, 9 (08) : 1 - 16
  • [29] Immune cell expression patterns of CD39/CD73 ectonucleotidases in rodent models of cardiac arrest and resuscitation
    Aoki, Tomoaki
    Wong, Vanessa
    Yin, Tai
    Nakamura, Eriko
    Endo, Yusuke
    Hayashida, Kei
    Robson, Simon C.
    Nandurkar, Harshal
    Diamond, Betty
    Kim, Sun Jung
    Murao, Atsushi
    Wang, Ping
    Becker, Lance B.
    Shinozaki, Koichiro
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [30] Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
    Kashyap, Abhishek S.
    Thelemann, Tamara
    Klar, Richard
    Kallert, Sandra M.
    Festag, Julia
    Buchi, Melanie
    Hinterwimmer, Lisa
    Schell, Monika
    Michel, Sven
    Jaschinski, Frank
    Zippelius, Alfred
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345